Leprosy Mailing List – July 13, 2022
Ref.: (LML) Infolep monthly overview of new publications on leprosy - Jul '22
From: Anniek Akerboom, Amsterdam, the Netherlands
Dear colleagues,
In the past month, the Kigali Summit took place. World leaders gathered in Rwanda and made firm commitments towards ending NTDs by the end of the decade. Click here to read the official Summit Outcome Statement.
The WHO launched the strategic framework for the integrated control and management of skin NTDs. The framework emphasizes an integrated approach to enable countries to tackle the morbidity, disability and psychosocial impact of skin NTDs by identifying areas, key partners and resources. Click here to watch the official launch of the framework.
The Leprosy Research Initiative (LRI) published recordings from their Annual Spring Meeting 2022 that took place 7 and 8 April. Go to the LRI website >> to watch the sessions you were unable to attend or to relive some of your LRI Spring Meeting moments.
Enjoy reading the latest publications on leprosy and have a look at the upcoming events below. Also, I would be happy to assist you with literature searches on Infolep.
Warm regards,
Anniek Akerboom
Infolep Coordinator
www.leprosy-information.org
a.akerboom@infolep.org
Highlighted
World Health Organization. 2022.
An Introductory Manual to Remote Service Provision for Supporting People with Disability and Leprosy
The Leprosy Mission Myanmar, NOREC. 2022.
Remote disability and leprosy services via basic communications technology
Theint ZM, Htun ZL, Swe KM, et al. Lepra. Leprosy Review. 2022; 93 (2) : 166-171.
Health and ethnic inequalities in Mozambique with special reference to leprosy
Casimiro IM, Machele J. UNU-WIDER. WIDER Working Paper. 2022.
Leprosy & COVID-19
Hansen's disease case detection in Brazil: a backlog of undiagnosed cases due to COVID-19 pandemic.
Deps P, Collin S, de Andrade V. Journal of the European Academy of Dermatology and Venereology : JEADV. 2022.
Comment on "Multibacillary leprosy unmasked by COVID-19 vaccination".
Hanumanthu V, Narang T, Dogra S. JAAD case reports. 2022.
New publications
Feel free to contact me to receive full-text versions if these cannot be found through the Infolep portal.
Leprosy stigma and its effect on the marriage experience of leprosy affected people and their descendants: the case of Addis-Tesfa Hiwot settlements in Ethiopia
Ayele H. Lepra. Leprosy Review. 2022; 93 (2) : 149-160.
Investigación del estigma y las comorbilidades del paciente con Lepra
Juan Jimenez C, Lopez Echevarria JR, Martínez Pérez A, et al. Universidad de Alcala. Revista de Investigación y Educación en Ciencias de la Salud (RIECS). 2022; 7 (1) : 41-51.
Sociodiscursive representations about leprosy in educational campaigns: implications on stigma reduction
Arantes EO, Lana FCF. FapUNIFESP (SciELO). Revista Brasileira de Enfermagem. 2022;
The quality of life of patients diagnosed with leprosy in a city in Piauí
Pereira de Souza IC, Guedes Alencar Correia V, Velôso HP, et al. Universidade Federal do Piaui. Rev Enferm UFPI. 2022.
Correlation between quality of life and the clinical results of patients with leprosy with drop foot after tendon transfer
Cohen J, Rodrigues N, Cabral E, et al. Acta ortopedica brasileira. 2022; 30 (3) : e244354.
Social participation restriction among persons with leprosy discharged from a multidrug therapy clinic in northern Nigeria.
Dahiru T, Iliyasu Z, Aliyu M. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2022.
Factors Influencing Leprosy-Affected People for Migration, Distant Registration and their Effect on Leprosy Services in Bangladesh
Hossain QZ, Hadi MA, Azad-uz-zaman Q, et al. Indian Journal of Leprosy. 2022.
Leprosy patients with deformities at post-elimination stage: The Bangladesh experience.
Mowla M, Angkur D, Hasan Z, et al. Skin health and disease. 2021; 1 (1) : e5.
National Health Survey reveals high percentage of signs and symptoms of leprosy in Brazil.
Penna G, Pontes M, Nobre M, et al. Ciencia & saude coletiva. 2022; 27 (6) : 2255-2258.
Território, doenças negligenciadas e ação de agentes comunitários e de combate a endemias
García GSM, Souza EAD, Araújo VMD, et al. Universidade de Sao Paulo, Agencia USP de Gestao da Informacao Academica (AGUIA). Revista de Saúde Pública. 2022.
Association of CD209 (DC-SIGN) rs735240 SNV with paucibacillary leprosy in the Brazilian population and its functional effects.
Germano G, Braga A, de Camargo R, et al. Memorias do Instituto Oswaldo Cruz. 2022.
The two extremes of Hansen's disease-Different manifestations of leprosy and their biological consequences in an Avar Age (late 7th century CE) osteoarchaeological series of the Duna-Tisza Interfluve (Kiskundorozsma-Daruhalom-dűlő II, Hungary).
Spekker O, Tihanyi B, Kis L, et al. PloS one. 2022; 17 (6) : e0265416.
Understanding leprosy reactions and the impact on the lives of people affected: An exploration in two leprosy endemic countries.
Putri A, de Sabbata K, Agusni R, et al. PLoS neglected tropical diseases. 2022; 16 (6) : e0010476.
Clinical profile of patients with pure neuritic leprosy: 20 years' experience at a tertiary referral centre from North India
Bhalla M, Poonia K, Jain S, et al. Lepra. Leprosy Review. 2022; 93 (2) : 131-137.
Associated factors study into the belated screening for leprosy in Benin.
Gnimavo R, Sopoh G, Djossou P, et al. PLoS neglected tropical diseases. 2022; 16 (6) : e0010533.
Beneficial Effect of Minocycline as Additional Treatment to Prednisone for Pustular Erythema Nodosum Leprosum.
Gunawan H, Faldian Y, Hindritiani R. International medical case reports journal. 2022.
The Type I Interferon Pathway Is Upregulated in the Cutaneous Lesions and Blood of Multibacillary Leprosy Patients With Erythema Nodosum Leprosum.
Rosa T, Mendes M, Linhares N, et al. Frontiers in medicine. 2022.
Safer and newer antimicrobial drugs for leprosy – time to test monthly ROM in an adequately powered randomised trial?
Lockwood DNJ, Penna GO, Lambert S, et al. Lepra. Leprosy Review. 2022; 93 (2) : 96-101.
Ofloxacin resistance in multibacillary new leprosy cases from Purulia, West Bengal: A threat to effective secondary line treatment for rifampicin resistant leprosy cases.
Ahuja M, Singh I, Lavania M, et al. Journal of global antimicrobial resistance. 2022.
Evaluation of the integrity of the facial muscles in leprosy patients using surface electromyography: a cross-sectional study
de Oliveira MF, dos Santos DF, Peres LB, et al. Lepra. Leprosy Review. 2022; 93 (2) : 115-130.
A review of nutrition in neuropathic pain of leprosy.
Klowak M, Boggild A. Therapeutic advances in infectious disease. 2022.
Are the clinical features of leprosy and American tegumentary leishmaniasis worse in patients with both diseases?
de Carvalho A, Luz J, Steinmann P, et al. Revista do Instituto de Medicina Tropical de Sao Paulo. 2022.
A study of histopathological spectrum of leprosy at tertiary care hospital
Patel PR, Patel K, Vyas J, et al. IP Innovative Publication Pvt Ltd. Indian Journal of Pathology and Oncology. 2022; 9 (1) : 16-20.
The Presence of Mycobacterium leprae in Wild Rodents.
de Lima M, Silvestre M, Santos E, et al. Microorganisms. 2022.
Effective amelioration of lucio phenomenon with adjuvant tofacitinib therapy in a patient with dual infection of M. leprae and M. lepromatosis : A case report from India.
Patel NH, Padhiyar JK, Patel KA, et al. Microbiology Society. 2022.
Events
Leprosy Research Initiative Spring Meeting 2022
7-8 April | Recordings
WHO Launch of the strategic framework for the integrated control and management of skin NTDs
8 June | Recording
COR-NTD Research Review: Mental Health and Stigma
22 June | Recording
TLMI Webinar: How close are we to being able to diagnose leprosy in the field?
28 June | Recording
iCHORDS Knowledge Exchange café: Using Rapid Qualitative Assessments to Improve Mass Drug Administration
21 July | Online event
NNN Conference
13-15 Sep 2022
Kathmandu & Virtual
COR-NTD Annual Meeting 2022
4 - 5 Oct | Virtual
21st International Leprosy Congress
8-11 Nov 2022
Hyderabad & Virtual
Links
Info Hansen - A innovative hub for knowledge sharing about Hansen's Disease
ALLF - Official website of the Association des Léprologues de Langue Française
LML - Leprosy Mailing List - a free moderated email list that allows all persons interested in leprosy to share ideas, information, experiences and questions
InfoNTD - Information on cross-cutting issues in Neglected Tropical Diseases (NTDs)
WHO Goodwill Ambassador's Leprosy Bulletin
Leprosy Review Repository (1928-2001)
Fontilles Revista de Leprología
GDPR & the Infolep newsletter
New EU data protection regulations came into force on 25 May 2018. We have been reviewing our practices with regards to the GDPR, including our privacy statement and mailing list.
Infolep sends out monthly e-mails with an overview of recent publications on leprosy and related issues. The purpose of this activity is to keep subscribers up to date.
Infolep will only process the data we have (names, email addresses) for the purpose of sending you the newsletter. We take your security seriously and will never share your contact details with anyone else.
You can update your preferences or unsubscribe from this list at any time.
LML - S Deepak, B Naafs, S Noto and P Schreuder
LML blog link: http://leprosymailinglist.blogspot.it/
Contact: Dr Pieter Schreuder << editorlml@gmail.com
--You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/c59bd9cc-359e-429d-a58c-c9260573b43cn%40googlegroups.com.
No comments:
Post a Comment